BOTOTLSJU
AKYA

Board of Trustees of The Leland Stanford Junior University’s Akoya BioSciences AKYA Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-620,433
Closed -$3.03M – 27
2023
Q4 		$3.03M Sell
620,433
-1
-0% -$4 0.2% 13
2023
Q3 		$2.89M Hold
620,434
– – 0.22% 9
2023
Q2 		$4.58M Buy
620,434
+1
+0% +$7 0.46% 11
2023
Q1 		$5.08M Sell
620,433
-1
-0% -$10 0.47% 11
2022
Q4 		$5.94M Sell
620,434
-153,682
-20% -$1.89M 0.6% 9
2022
Q3 		$9.1M Sell
774,116
-798,745
-51% -$10.5M 0.58% 14
2022
Q2 		$20.2M Sell
1,572,861
-2
-0% -$21 1.36% 10
2022
Q1 		$17.3M Sell
1,572,863
-52,695
-3% -$611K 0.98% 9
2021
Q4 		$28.6M Sell
1,625,558
-618,217
-28% -$8.09M 1.79% 11
2021
Q3 		$31.3M Hold
2,243,775
– – 2.33% 8
2021
Q2 		$43.4M Buy
+2,243,775
New +$46.3M 4.05% 6

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's AKYA Position: Q1 2024 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Akoya BioSciences (AKYA) in Q1 2024, closing a stake of 620,433 shares — an estimated $3.03M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in AKYA in Q2 2021 and held it in 11 quarters. The position peaked at $43.4M in Q2 2021. 68 funds tracked by Wall St. Rank hold AKYA as of Q1 2024.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining Akoya BioSciences position as of Q1 2024 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 620,433 Akoya BioSciences shares in Q1 2024, an estimated $3.03M.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in Akoya BioSciences in Q2 2021 and held it in 11 quarters.
  • Board of Trustees of The Leland Stanford Junior University's Akoya BioSciences position peaked at $43.4M in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2024.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q1 2024, filed 15 May 2024.